12/31
09:37 am
lexx
Lexaria releases additional results from Phase 1b study GLP-1-H24-4 [Yahoo! Finance]
High
Report
Lexaria releases additional results from Phase 1b study GLP-1-H24-4 [Yahoo! Finance]
12/26
07:17 am
lexx
Lexaria Bioscience (NASDAQ:LEXX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Lexaria Bioscience (NASDAQ:LEXX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/9
04:25 pm
lexx
Lexaria Bioscience (NASDAQ:LEXX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Lexaria Bioscience (NASDAQ:LEXX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/7
01:06 am
lexx
Lexaria Bioscience (NASDAQ:LEXX) was downgraded by analysts at
Wall Stre
Medium
Report
Lexaria Bioscience (NASDAQ:LEXX) was downgraded by analysts at
Wall Stre
12/3
04:31 pm
lexx
Lexaria Bioscience (NASDAQ:LEXX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Lexaria Bioscience (NASDAQ:LEXX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/29
08:47 am
lexx
Lexaria Bioscience Corp. (NASDAQ:LEXX): Are Analysts Optimistic? [Yahoo! Finance]
Medium
Report
Lexaria Bioscience Corp. (NASDAQ:LEXX): Are Analysts Optimistic? [Yahoo! Finance]
11/29
03:35 am
lexx
Lexaria Bioscience (NASDAQ:LEXX) was upgraded by analysts at
Wall Street
Medium
Report
Lexaria Bioscience (NASDAQ:LEXX) was upgraded by analysts at
Wall Street
11/27
02:50 pm
lexx
Lexaria Bioscience (NASDAQ:LEXX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Lexaria Bioscience (NASDAQ:LEXX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/21
02:02 pm
lexx
Lexaria Bioscience (NASDAQ:LEXX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Neutral
Report
Lexaria Bioscience (NASDAQ:LEXX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
09:26 am
lexx
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended [Yahoo! Finance]
Low
Report
Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended [Yahoo! Finance]